Eliassen Strategic Insights

Business Development Intelligence Portal

Your strategic command center for winning enterprise partnerships in 2025-2026

🎯 Target Accounts Ready💰 $615M+ Pipeline Identified🚀 Fast-Path Strategies🏆 Competitive Win Tactics
0
Years of Expertise
0
Industry Sectors
0
Service Areas
0
Growth Markets

🎯 BD Playbook 2025-2026

Win Strategies, Talking Points & Target Accounts

Complete business development framework with competitive win tactics, executive conversation starters, and fast-path strategies to close partnerships 3x faster than competitors.

Fast-Path Advantages

  • • 50-70% cost advantage vs Big 4
  • • 2-4 weeks vs 8-12 weeks deployment
  • • 12% vs 22% attrition rate

2025-2026 Hot Topics

  • • Agentic AI & Gen AI Production
  • • Federal Zero-Trust & CMMC 2.0
  • • Healthcare RWE Modernization

Target Priorities

  • • 4 immediate opportunities (0-3 mo)
  • • $615M+ total pipeline identified
  • • Win strategies vs competitors
🔥 BREAKING NEWS
🏥

Abbott Acquires Exact Sciences - $23B Deal

Major Cancer Diagnostics Integration Opportunity • Nov 20, 2025

Abbott's massive acquisition of Exact Sciences creates $65-133M integration opportunity across IT systems, LIMS, regulatory compliance, international expansion, and digital transformation. Expected close Q2 2026.

Deal Value
$23B
Eliassen Opportunity
$65-133M
Close Date
Q2 2026
Priority Areas
10+
View Full Acquisition Analysis & Strategy

🚀 Advanced Intelligence

McKinsey + Gartner Insights

Cutting-edge research revealing $615M+ pipeline across Agentic AI, Enterprise Modernization, Healthcare Tech Resilience, Federal Zero-Trust, Embedded Finance, and Quantum Computing. November 2025 intelligence.

Explore Advanced Intel

Predictive Opportunities

AI-Powered Market Intelligence

6 high-probability revenue opportunities totaling $200-400M pipeline across Gen AI production, RWE pharma, federal zero-trust, and emerging markets. Time-sensitive buying triggers identified for Q1-Q2 2025.

View Opportunities